Department of Anesthesiology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA,
J Anesth. 2013 Oct;27(5):705-11. doi: 10.1007/s00540-013-1601-0. Epub 2013 Apr 5.
Hereditary hemorrhagic telangiectasia is a rare autosomal dominant disease characterized by capillary malformation leading to multisite cutaneomucosal telangiectasias and multiorgan arteriovenous malformations, which can present challenges to anesthetic care. The primary aim of this report is to present a large cohort of patients with hereditary hemorrhagic telangiectasia undergoing general anesthesia at our institution in regard to comorbid conditions and complications of surgical and anesthetic management.
A computerized search from January 1, 2002 through December 31, 2011 of the Mayo Clinic medical records database was performed for patients with hereditary hemorrhagic telangiectasia who underwent general anesthesia. Medical records were reviewed. Eligibility criteria included patients with definite or suspected hereditary hemorrhagic telangiectasia based on the Curacao diagnostic criteria who underwent general anesthesia during the study period.
We identified 74 patients with hereditary hemorrhagic telangiectasia who underwent 163 surgeries. The majority had pulmonary arteriovenous malformations (56.7%) and iron deficiency anemia (64.7%), and high levels of disease burden with a median American Society of Anesthesiologist Physical Status score of 3. Most surgeries were related to treating conditions associated with hereditary hemorrhagic telangiectasia, with the majority being procedures to the nasal mucosa for recurrent epistaxis (47.2%). A sizeable proportion of procedures to the nasal mucosa required transfusion of blood (12/77). One case of epistaxis required 11 units of blood until it was successfully controlled. Another notable complication included migration of a coil to pulmonary arteriovenous malformations into the cerebral circulation.
Surgical patients with hereditary hemorrhagic telangiectasia often present with multiorgan involvement. The anesthesia provider needs to be aware of the high prevalence of pulmonary arteriovenous malformations, which may be asymptomatic but can lead to embolic complications. Hemorrhage from epistaxis can be severe, and relatively focal procedures to the nasal mucosa can require blood transfusions.
遗传性出血性毛细血管扩张症是一种罕见的常染色体显性遗传性疾病,其特征为毛细血管畸形,导致多部位皮肤黏膜毛细血管扩张和多器官动静脉畸形,这可能给麻醉管理带来挑战。本报告的主要目的是介绍在我们机构接受全身麻醉的遗传性出血性毛细血管扩张症患者的大样本队列,涉及合并症以及手术和麻醉管理的并发症。
对 2002 年 1 月 1 日至 2011 年 12 月 31 日期间在梅奥诊所医疗记录数据库中进行了计算机检索,以查找接受全身麻醉的遗传性出血性毛细血管扩张症患者。对病历进行了审查。入选标准包括根据 Curacao 诊断标准确诊或疑似遗传性出血性毛细血管扩张症且在研究期间接受全身麻醉的患者。
我们确定了 74 例接受全身麻醉的遗传性出血性毛细血管扩张症患者,共进行了 163 次手术。大多数患者有肺动静脉畸形(56.7%)和缺铁性贫血(64.7%),疾病负担高,美国麻醉医师协会身体状况评分中位数为 3 分。大多数手术与治疗遗传性出血性毛细血管扩张症相关的疾病有关,其中大部分是治疗因复发性鼻出血而进行的鼻腔黏膜手术(47.2%)。相当一部分鼻腔黏膜手术需要输血(77 例中有 12 例)。一例鼻出血需要输注 11 单位的血液才能成功控制。另一个值得注意的并发症包括一个线圈迁移到肺动静脉畸形并进入脑循环。
遗传性出血性毛细血管扩张症的手术患者通常有多器官受累。麻醉提供者需要了解肺动静脉畸形的高患病率,肺动静脉畸形可能无症状,但可导致栓塞性并发症。鼻出血可能很严重,而相对局限的鼻腔黏膜手术可能需要输血。